COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients

NCT05054218 · clinicaltrials.gov ↗
COMPLETED
Status
336
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators